MetaADEDB 2.0 @ LMMD
Estradiol
(RSEPBGGWRJCQGY-RBRWEJTLSA-N)
Structure
SMILES
CCCCC(=O)O[C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCc2c1ccc(c2)O
Type(s)
Approved; Investigational; Vet_approved
Molecular Formula:
C23H32O3
Molecular Weight:
356.498
Log P:
5.3503
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
1
TPSA:
46.53
CAS Number(s):
979-32-8
Synonym(s)
1.
Estradiol
2.
17 beta-Estradiol
3.
Estradiol-17 beta
4.
Oestradiol
5.
17 beta-Oestradiol
6.
Aerodiol
7.
Delestrogen
8.
Estrace
9.
Estraderm TTS
10.
Estradiol Anhydrous
11.
Estradiol Hemihydrate
12.
Estradiol Hemihydrate, (17 alpha)-Isomer
13.
Estradiol Monohydrate
14.
Estradiol Valerate
15.
Estradiol Valeriante
16.
Estradiol, (+-)-Isomer
17.
Estradiol, (-)-Isomer
18.
Estradiol, (16 alpha,17 alpha)-Isomer
19.
Estradiol, (16 alpha,17 beta)-Isomer
20.
Estradiol, (17-alpha)-Isomer
21.
Estradiol, (8 alpha,17 beta)-(+-)-Isomer
22.
Estradiol, (8 alpha,17 beta)-Isomer
23.
Estradiol, (9 beta,17 alpha)-Isomer
24.
Estradiol, (9 beta,17 beta)-Isomer
25.
Estradiol, Monosodium Salt
26.
Estradiol, Sodium Salt
27.
Estradiol-17 alpha
28.
Estradiol-17beta
29.
Ovocyclin
30.
Progynon-Depot
31.
Progynova
32.
Vivelle
33.
17 beta Estradiol
34.
17 beta Oestradiol
35.
Estradiol 17 alpha
36.
Estradiol 17 beta
37.
Estradiol 17beta
38.
Progynon Depot
External Link(s)
MeSHD004958
PubChem Compound13791
ChEBI31561
CHEMBLCHEMBL1511
DrugBankDB13956
DrugCentral1064
IUPHAR/BPS Guide to PHARMACOLOGY7655
KEGGcpd:C12859
dr:D01413
ZINC3881556
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 14US FAERS
2Product quality issueFAERS: 9US FAERS
3HeadacheFAERS: 6US FAERS
4VomitingFAERS: 4US FAERS
5Contraindicated product administeredFAERS: 3US FAERS
6Drug ineffective for unapproved indicationFAERS: 3US FAERS
7Hormone level abnormalFAERS: 3US FAERS
8MalaiseFAERS: 3US FAERS
9Product use issueFAERS: 3US FAERS
10UrticariaFAERS: 3US FAERS
11Abdominal discomfortFAERS: 2US FAERS
12Burning sensationFAERS: 2US FAERS
13Cerebrovascular accidentFAERS: 2US FAERS
14Drug dispensing errorFAERS: 2OFFSIDES
US FAERS
15Drug exposure during pregnancyFAERS: 2OFFSIDES
US FAERS
16FatigueFAERS: 2US FAERS
17Incorrect dose administeredFAERS: 2US FAERS
18Insulin ResistanceFAERS: 2US FAERS
19Medical dietFAERS: 2US FAERS
20Medication ErrorFAERS: 2US FAERS
21NauseaFAERS: 2OFFSIDES
US FAERS
22No adverse reactionFAERS: 2US FAERS
23Peripheral swellingFAERS: 2US FAERS
24PregnancyFAERS: 2US FAERS
25PruritusFAERS: 2US FAERS
26SinusitisFAERS: 2OFFSIDES
US FAERS
27StressFAERS: 2US FAERS
28SwellingFAERS: 2US FAERS
29AlopeciaFAERS: 1US FAERS
30Arterial thrombosisFAERS: 1US FAERS
31ArthralgiaFAERS: 1US FAERS
32AsthmaFAERS: 1US FAERS
33BedriddenFAERS: 1US FAERS
34Chest discomfortFAERS: 1US FAERS
35CholelithiasisFAERS: 1US FAERS
36Contraindicated drug administeredFAERS: 1US FAERS
37Death of relativeFAERS: 1US FAERS
38Device occlusionFAERS: 1US FAERS
39DiplopiaFAERS: 1US FAERS
40Drug administered at inappropriate siteFAERS: 1US FAERS
41DyspepsiaFAERS: 1US FAERS
42Emotional disorderFAERS: 1US FAERS
43Expired product administeredFAERS: 1US FAERS
44Feeling abnormalFAERS: 1US FAERS
45Gastric BypassFAERS: 1US FAERS
46HypersensitivityFAERS: 1US FAERS
47Hypertensive crisisFAERS: 1US FAERS
48Immature respiratory systemFAERS: 1US FAERS
49Inability to afford medicationFAERS: 1US FAERS
50Incorrect drug administration durationFAERS: 1US FAERS
51Incorrect route of drug administrationFAERS: 1US FAERS
52Infantile apnoeic attackFAERS: 1US FAERS
53Injection site cellulitisFAERS: 1US FAERS
54Injection site urticariaFAERS: 1US FAERS
55Joint swellingFAERS: 1US FAERS
56Liquid product physical issueFAERS: 1US FAERS
57Maternal exposure before pregnancyFAERS: 1US FAERS
58OtosclerosisFAERS: 1US FAERS
59OverdoseFAERS: 1US FAERS
60PalpitationsFAERS: 1US FAERS
61Portal Vein ThrombosisFAERS: 1US FAERS
62Product package associated injuryFAERS: 1US FAERS
63Product packaging issueFAERS: 1US FAERS
64Product substitution issueFAERS: 1US FAERS
65Product use complaintFAERS: 1US FAERS
66Product use in unapproved indicationFAERS: 1US FAERS
67Quality of life decreasedFAERS: 1US FAERS
68Skin irritationFAERS: 1US FAERS
69ThrombosisFAERS: 1US FAERS
70Trisomy 21FAERS: 1US FAERS
71Uterine cervical exfoliationFAERS: 1US FAERS
72Wrong technique in product usage processFAERS: 1US FAERS
73pH body fluid abnormalFAERS: 1US FAERS
74Abdominal adhesionsOFFSIDES
75ActinomycosisOFFSIDES
76Acute bronchitisOFFSIDES
77Acute myocardial infarctionOFFSIDES
78AgraphiaOFFSIDES
79Alcohol consumptionOFFSIDES
80Altered bowel functionOFFSIDES
81AngioedemaOFFSIDES
82AnhedoniaOFFSIDES
83AnosmiaOFFSIDES
84AnxietyOFFSIDES
85ApathyOFFSIDES
86Arthropod biteOFFSIDES
87BereavementOFFSIDES
88BiopsyOFFSIDES
89Blood cholesterolOFFSIDES
90Bone infarctionOFFSIDES
91BronchitisOFFSIDES
92BruxismOFFSIDES
93Catheter related infectionOFFSIDES
94Chronic Obstructive Airway DiseaseOFFSIDES
95Circumstance or information capable of leading to medication errorOFFSIDES
96CirrhosisOFFSIDES
97Dental FistulaOFFSIDES
98DependenceOFFSIDES
99Device related infectionOFFSIDES
100DiabetesOFFSIDES
101Drug resistanceOFFSIDES
102DysphasiaOFFSIDES
103Economic problemOFFSIDES
104Emotional distressOFFSIDES
105FibromyalgiaOFFSIDES
106Fistula dischargeOFFSIDES
107GamblingOFFSIDES
108HysteroscopyOFFSIDES
109Intranasal numbnessOFFSIDES
110LethargyOFFSIDES
111Multiple MyelomaOFFSIDES
112Muscle strainOFFSIDES
113Nasal discomfortOFFSIDES
114OsteomyelitisOFFSIDES
115Ovarian Hyperstimulation SyndromeOFFSIDES
116PainOFFSIDES
117PeritonitisOFFSIDES
118Pharmaceutical product complaintOFFSIDES
119Pituitary enlargementOFFSIDES
120Pregnancy test positiveOFFSIDES
121Progesterone receptor assayOFFSIDES
122ScreamingOFFSIDES
123Tooth ExtractionOFFSIDES
124Vascular calcificationOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.